The serine protease granzyme B as an inflammatory marker, in relation to the insulin receptor cleavage in human obesity and type 2 diabetes mellitus

Journal of Interferon and Cytokine Research

Volumn 34, Issue 3, 2014, Pages 179-186

  El Mesallamy, Hala O ^a   Hamdy, Nadia M ^a   Mostafa, Dina M ^a   Amin, Ashraf I ^b  

^a African Union Organization St Abbassia   (Egypt)

^b National Institute of Diabetes and Endocrinology (NIDE)   (Egypt)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; GRANZYME B; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; INSULIN RECEPTOR; INSULIN RECEPTOR ALPHA; INTERLEUKIN 1BETA; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ADULT; ANTHROPOMETRY; ARTICLE; BODY MASS; CHOLESTEROL BLOOD LEVEL; DIABETIC PATIENT; ENZYME BLOOD LEVEL; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GLUCOSE BLOOD LEVEL; HEMOGLOBIN BLOOD LEVEL; HUMAN; INFLAMMATION; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; METABOLIC PARAMETERS; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN CLEAVAGE; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE; WAIST HIP RATIO;

ANTIGENS, CD; BIOLOGICAL MARKERS; BLOOD GLUCOSE; BODY MASS INDEX; DIABETES MELLITUS, TYPE 2; FEMALE; GRANZYMES; HUMANS; INFLAMMATION; INSULIN RESISTANCE; INTERLEUKIN-1BETA; MALE; MIDDLE AGED; OBESITY; RECEPTOR, INSULIN;

EID: 84895880894     PISSN: 10799907     EISSN: 15577465     Source Type: Journal    
DOI: 10.1089/jir.2013.0059     Document Type: Article

References (49)

1. Afonina IS, Cullen SP, Martin SJ. 2010. Cytotoxic and noncytotoxic roles of the CTL/NK protease granzyme B. Immunol Rev 235(1):105-116
2. Afonina IS, Tynan GA, Logue SE, Cullen SP, Bots M, Lüthi AU, Reeves EP, McElvaney NG, Medema JP, Lavelle EC, Martin SJ. 2011. Granzyme B-dependent proteolysis acts as a switch to enhance the proinflammatory activity of IL-1a. Mol cell 44(2):265-278
3. Ang LS, Boivin WA, Williams SJ, Zhao H, Abraham T, Carmine-Simmen K, McManus BM, Bleackley RC, Granville DJ. 2011. Serpina3n attenuates granzyme B-mediated decorin cleavage and rupture in a murine model of aortic aneurysm. Cell Death Dis 2(2):e209
4. Bird CH, Sun J, Ung K, Karambalis D, Whisstock JC, Trapani JA, Bird PI. 2005. Cationic sites on granzyme B contribute to cytotoxicity by promoting its uptake into target cells. Mol Cell Biol 25(17):7854-7867
5. Boivin WA, Cooper DM, Hiebert PR, Granville DJ. 2009. Intracellular versus extracellular granzyme B in immunity and disease: Challenging the dogma. Lab Invest 89(11):1195-1220
6. Bratke K, Bottcher B, Leeder K, Schmidt S, Kupper M, Virchow JC, Luttmann W. 2004. Increase in granzyme B + lymphocytes and soluble granzyme B in bronchoalveolar lavage of allergen challenged patients with atopic asthma. Clin Exp Immunol 136(3):542-548
7. Chamberlain CM, Ang LS, Boivin WA, Cooper DM, Williams SJ, Zhao H, Hendel A, Folkesson M, Swedenborg J, Allard MF, McManus BM, Granville DJ. 2010. Perforin-independent extracellular granzyme B activity contributes to abdominal aortic aneurysm. Am J Pathol 176(2):1038-1049
8. Chowdhury D, Lieberman J. 2008. Death by a thousand cuts: Granzyme pathways of programmed cell death. Annu Rev Immunol 26(1):389-420
9. DeLano FA, Zhang H, Tran EE, Zhang C, Schmid-Schönbein GW. 2010. New hypothesis for insulin resistance in hypertension due to receptor cleavage. Expert Rev Endocrinol Metab 5(1):149-158
10. Donath MY, Shoelson SE. 2011. Type 2 diabetes as an inflammatory disease. Nat Rev Immunol 11(2):98-107
11. El-Mesallamy HO, El-Derany MO, Hamdy NM. 2011a. Serum omentin-1 and chemerin levels are interrelated in patients with type 2 diabetes mellitus with or without ischaemic heart disease. Diabet Med 28(10):1194-1200
12. El-Mesallamy HO, Hamdy NM, Rizk HH, El-Zayadi A-R. 2011b. Apelin serum level in Egyptian patients with chronic hepatitis C. Mediators Inflamm 2011:1-7
13. El-Mesallamy HO, Hamdy NM, Salman TM, Ibrahim SM. 2012. Adiponectin and sE-selectin concentrations in relation to inflammation in obese type 2 diabetic patients with coronary heart disease. Angiology 63(2):96-102
14. Estella E, McKenzie MD, Catterall T, Sutton VR, Bird PI, Trapani JA, Kay TW, Thomas HE. 2006. Granzyme B-mediated death of pancreatic beta-cells requires the proapoptotic BH3-only molecule bid. Diabetes 55(8):2212-2219
15. Ewen CL, Kane KP, Bleackley RC. 2012. A quarter century of granzymes. Cell Death Differ 19(1):28-35
16. Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. 2003. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 26(suppl 1):s5-s20
17. Ganor Y, Teichberg VI, Levite M. 2007. TCR activation eliminates glutamate receptor GluR3 from the cell surface of normal human T Cells, via an autocrine/paracrine granzyme B-mediated proteolytic cleavage. J Immunol 178(2):683-692
18. Hendel A, Hiebert PR, Boivin WA, Williams SJ, Granville DJ. 2010. Granzymes in age-related cardiovascular and pulmonary diseases. Cell Death Differ 17(4):596-606
19. Hiebert PR, Boivin WA, Abraham T, Pazooki S, Zhao H, Granville DJ. 2011. Granzyme B contributes to extracellular matrix remodeling and skin aging in apolipoprotein E knockout mice. Exp Gerontol 46(6):489-499
20. Ikemoto T, Hojo Y, Kondo H, Takahashi N, Hirose M, Nishimura Y, Katsuki T, Shimada K. 2009. Plasma granzyme B as a predicting factor of coronary artery disease-clinical significance in patients with chronic renal failure. J Cardiol 54(3):409-415
21. Isaaz S, Baetz K, Olsen K, Podack E, Griffiths GM. 1995. Serial killing by cytotoxic T lymphocytes: T cell receptor triggers degranulation, re-filling of the lytic granules and secretion of lytic proteins via a non-granule pathway. Eur J Immunol 25(4):1071-1079
22. Jenne DE, Tschopp J. 1988. Granzymes, a family of serine proteases released from granules of cytolytic T lymphocytes upon T cell receptor stimulation. Immunol Rev 103(1):53-71
23. Katz A, Nambi SS, Mather K, Baron AD, Follmann DA, Sullivan G, Quon MJ. 2000. Quantitative insulin sensitivity check index: A simple, accurate method for assessing insulin sensitivity in humans. J Clin Endocrinol Metab 85(7):2402-2410
24. Kondo H, Hojo Y, Tsuru R, Nishimura Y, Shimizu H, Takahashi N, Hirose M, Ikemoto T, Ohya K-i, Katsuki T, Yashiro T, Shimada K. 2009. Elevation of plasma granzyme B levels after acute myocardial infarction. Circ J 73(3):503-507
25. Loeb CR, Harris JL, Craik CS. 2006. Granzyme B proteolyzes receptors important to proliferation and survival, tipping the balance toward apoptosis. J Biol Chem 281(38):28326-28335
26. Lumeng CN, Bodzin JL, Saltiel AR. 2007. Obesity induces a phenotypic switch in adipose tissue macrophage polarization. J Clin Invest 117(1):175-184
27. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. 1985. Homeostasis model assessment: Insulin resistance and b-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28(7):412-419
28. Metkar SS, Menaa C, Pardo J, Wang B, Wallich R, Freudenberg M, Kim S, Raja SM, Shi L, Simon MM, Froelich CJ. 2008 Human and mouse granzyme A induce a proinflammatory cytokine response. Immunity 29(5):720-733
29. Mlinar B, Marc J, Janež A, Pfeifer M. 2007. Molecular mechanisms of insulin resistance and associated diseases. Clin Chim Acta 375(1-2):20-35
30. Mollah ZU, Graham KL, Krishnamurthy B, Trivedi P, Brodnicki TC, Trapani JA, Kay TW, Thomas HE. 2012. Granzyme B is dispensable in the development of diabetes in non-obese diabetic mice. PLoS ONE 7(7):e40357
31. Nikolajczyk BS, Jagannathan-Bogdan M, Shin H, Gyurko R. 2011. State of the union between metabolism and the immune system in type 2 diabetes. Genes Immun 12(4):239-250
32. Nishimura S, Manabe I, Nagasaki M, Eto K, Yamashita H, Ohsugi M, Otsu M, Hara K, Ueki K, Sugiura S, Yoshimura K, Kadowaki T, Nagai R. 2009. CD8 + effector T cells contribute to macrophage recruitment and adipose tissue inflammation in obesity. Nat Med 15(8):914-920
33. Nishimura S, Manabe I, Nagasaki M, Seo K, Yamashita H, Hosoya Y, Ohsugi M, Tobe K, Kadowaki T, Nagai R, Sugiura S. 2008. In vivo imaging in mice reveals local cell dynamics and inflammation in obese adipose tissue. J Clin Invest 118(2):710-721
34. Obata T, Yokota I, Yokoyama K, Okamoto E, Kanezaki Y, Tanaka Y, Maegawa H, Teshigawara K, Hirota F, Yuasa T, Kishi K, Hattori A, Hashida S, Masuda K, Matsumoto M, Matsumoto T, Kashiwagi A, Ebina Y. 2007. Soluble insulin receptor ectodomain is elevated in the plasma of patients with diabetes. Diabetes 56:2028-2035
35. Odegaard JI, Ricardo-Gonzalez RR, Goforth MH, Morel CR, Subramanian V, Mukundan L, Eagle AR, Vats D, Brombacher F, Ferrante AW, Chawla A. 2007. Macrophage-specific PPARg controls alternative activation and improves insulin resistance. Nature 447(7148):1116-1120
36. Omoto Y, Yamanaka K, Tokime K, Kitano S, Kakeda M, Akeda T, Kurokawa I, Gabazza EC, Tsutsui H, Katayama N, Yamanishi K, Nakanishi K, Mizutani H. 2010. Granzyme B is a novel interleukin-18 converting enzyme. J Dermatol Sci 59(2):129-135
37. Prakash MD, Bird CH, Bird PI. 2008. Active and zymogen forms of granzyme B are constitutively released from cytotoxic lymphocytes in the absence of target cell engagement. Immunol Cell Biol 87(3):249-254
38. Ross R, Leger L, Morris D, De Guise J, Guardo R. 1992. Quantification of adipose tissue by MRI: Relationship with anthropometric variables. J Appl Physiol 72(2):787-795
39. Shoelson SE, Lee J, Goldfine AB. 2006. Inflammation and insulin resistance. J Clin Invest 116(7):1793-1801
40. Skjelland M, Michelsen AE, Krohg-Sørensen K, Tennøe B, Dahl A, Bakke S, Brosstad F, Damås JK, Russell D, Halvorsen B, Aukrust P. 2007. Plasma levels of granzyme B are increased in patients with lipid-rich carotid plaques as determined by echogenicity. Atherosclerosis 195(2):e142-e146
41. Stentz FB, Kitabchi AE. 2003. Activated T lymphocytes in type 2 diabetes: Implications from in vitro studies. Curr Drug Targets 4:493-503
42. Strissel KJ, Stancheva Z, Miyoshi H, Perfield JW, DeFuria J, Jick Z, Greenberg AS, Obin MS. 2007. Adipocyte death, adipose tissue remodeling, and obesity complications. Diabetes 56(12):2910-2918
43. Sutton VR, Estella E, Li C, Chen M, Thomas HE, Kay TW, Trapani JA. 2006. A critical role for granzyme B, in addition to perforin and TNFalpha, in alloreactive CTL-induced mouse pancreatic beta cell death. Transplantation 81(2):146-154
44. Tak PP, Spaeny-Dekking L, Kraan MC, Breedveld FC, Froelich CJ, Hack CE. 1999. The levels of soluble granzyme A and B are elevated in plasma and synovial fluid of patients with rheumatoid arthritis (RA). Clin Exp Immunol 116(2):366-370
45. Thomas HE, Trapani JA, Kay TWH. 2010. The role of perforin and granzymes in diabetes. Cell Death Differ 17(4):577-585
46. Tsuru R, Kondo H, Hojo Y, Gama M, Mizuno O, Katsuki T, Shimada K, Kikuchi M, Yashiro T. 2008. Increased granzyme B production from peripheral blood mononuclear cells in patients with acute coronary syndrome. Heart 94(3):305-310
47. Weisberg SP, McCann D, Desai M, Rosenbaum M, Leibel RL, Ferrante AW. 2003. Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest 112(12):1796-1808
48. World Health Organization. 2013. Obesity and overweight. Available atwww.who.int/mediacentre/factsheets/fs311/en/
49. Xu H, Barnes GT, Yang Q, Tan G, Yang D, Chou CJ, Sole J, Nichols A, Ross JS, Tartaglia LA, Chen H. 2003. Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J Clin Invest 112(12):1821-1830